Thus, the 177Lu-DN(C19)-CXCR4L nanosystem demonstrated a synergistic effect of chemo/radiation therapy, which could be implemented in colorectal cancer with mutated KRAS. This evidence concerns the gene KRAS and colorectal cancer.